Q34
Conditions
Interventions
Group 1: For all patients already diagnosed with or suspected of having chronic lung disease, a guideline-based, disease-specific examination plan. The examinations are repeated regularly on an indivi
Sponsors
Charité Universitätsmedizin Berlin Klinik für Pädiatrie m.S. Pneumologie, Immunologie und Intensivmedizin
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Patients with (suspected) chronic lung disease - Healthy control subjects without history or symptoms of lung disease
Exclusion criteria
Exclusion criteria: - Withdrawal from the study - Other serious medical conditions - medical findings that would reasonably be expected to compromise the safety of the patient or the quality of the study data
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the onset and progression of chronic lung disease at new diagnosis using clinical and diagnostic progression parameters covering the underlying aspects of lung disease (function, morphology, infection, and inflammation). | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the correlation of different diagnostic and course parameters also in connection with therapeutic measures | — |
Countries
Germany
Contacts
Public ContactJanette Tattersall-Wong
Charité - Universitätsmedizin Berlin
Outcome results
None listed